Therefore, we intended to investigate the distribution of IL‐10 promoter polymorphisms and their influence on disease susceptibility, severity, and prognosis in patients with GBS from a well‐documented cohort of Bangladesh. Here, IL10 is linked to Guillain-Barre syndrome.